The Kaplan-Meier survival curve of BLCA patients also be estimated according to the following three potential combinations of combined variables: p53 and PCDH17, p53 and Beclin-1, and PCDH17 and Beclin-1. This evidence concerns the gene BECN1 and bladder transitional cell carcinoma.